expert comment: caspian trial of durvalumab in sclc | raffaele califano
Published 5 years ago • 447 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
1:43
updated results from the caspian trial of durvalumab plus chemo in sclc
-
6:37
caspian trial: durvalumab and chemotherapy in es-sclc
-
4:57
chemoimmunotherapy for es sclc: caspian trial
-
2:07
extensive-stage sclc: potential in the caspian trial
-
4:40
emerging therapies for extensive stage sclc and caspian trial
-
6:06
stage iii nsclc: when to start durvalumab
-
7:06
types of cancer - squamous cell carcinoma vs adenocarcinoma
-
5:08
consolidation durvalumab could be new soc in limited-stage sclc
-
4:28
krebs - deshalb kämpfe ich nicht!
-
2:10
dr. langer on the benefit of durvalumab in stage iii nsclc
-
4:43
treating for stage iii nsclc after progression on durvalumab
-
3:44
the caspian trial in extensive-stage sclc
-
11:11
extending durvalumab maintenance to special populations
-
2:43
fda approves durvalumab / imfinzi for resectable nsclc non-small cell lung cancer
-
4:34
discussion of impower133 and caspian trials
-
4:15
safety profile of durvalumab in locally advanced nsclc
-
4:37
durvalumab: a new option for stage iii nsclc patients? | davey daniel
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
3:48
poseidon: durvalumab /- tremelimumab chemo in 1l mnsclc
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
2:15
the impact of durvalumab for resectable non-small cell lung cancer